Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan
From January 2019 to May 2021, 11 children underwent allogeneic stem cell transplantation at our institute. Four of them received letermovir for cytomegalovirus prophylaxis. Three children, none of whom received prophylaxis, experienced cytomegalovirus reactivation. Letermovir is a promising medicat...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-04-01
|
| Series: | Journal of Microbiology, Immunology and Infection |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1684118222000184 |
| _version_ | 1818264914867781632 |
|---|---|
| author | Chao-Neng Cheng Sin-Syue Li Yun-Hsuan Yeh Ching-Fen Shen Jiann-Shiuh Chen |
| author_facet | Chao-Neng Cheng Sin-Syue Li Yun-Hsuan Yeh Ching-Fen Shen Jiann-Shiuh Chen |
| author_sort | Chao-Neng Cheng |
| collection | DOAJ |
| description | From January 2019 to May 2021, 11 children underwent allogeneic stem cell transplantation at our institute. Four of them received letermovir for cytomegalovirus prophylaxis. Three children, none of whom received prophylaxis, experienced cytomegalovirus reactivation. Letermovir is a promising medication for use in cytomegalovirus prophylaxis in children. Further studies are warranted. |
| first_indexed | 2024-12-12T19:42:29Z |
| format | Article |
| id | doaj.art-0754ae26951f4819a523117258d0da84 |
| institution | Directory Open Access Journal |
| issn | 1684-1182 |
| language | English |
| last_indexed | 2024-12-12T19:42:29Z |
| publishDate | 2022-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Microbiology, Immunology and Infection |
| spelling | doaj.art-0754ae26951f4819a523117258d0da842022-12-22T00:14:10ZengElsevierJournal of Microbiology, Immunology and Infection1684-11822022-04-01552323327Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in TaiwanChao-Neng Cheng0Sin-Syue Li1Yun-Hsuan Yeh2Ching-Fen Shen3Jiann-Shiuh Chen4Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, TaiwanDepartment of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, TaiwanDepartment of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, TaiwanDepartment of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, TaiwanDepartment of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Corresponding author. Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138, Sheng-Li Rd, Tainan, 70403, Taiwan. Fax: +886 6 2753083.From January 2019 to May 2021, 11 children underwent allogeneic stem cell transplantation at our institute. Four of them received letermovir for cytomegalovirus prophylaxis. Three children, none of whom received prophylaxis, experienced cytomegalovirus reactivation. Letermovir is a promising medication for use in cytomegalovirus prophylaxis in children. Further studies are warranted.http://www.sciencedirect.com/science/article/pii/S1684118222000184ChildrenCytomegalovirusHematopoietic stem cell transplantationLetermovirProphylaxis |
| spellingShingle | Chao-Neng Cheng Sin-Syue Li Yun-Hsuan Yeh Ching-Fen Shen Jiann-Shiuh Chen Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan Journal of Microbiology, Immunology and Infection Children Cytomegalovirus Hematopoietic stem cell transplantation Letermovir Prophylaxis |
| title | Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan |
| title_full | Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan |
| title_fullStr | Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan |
| title_full_unstemmed | Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan |
| title_short | Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan |
| title_sort | letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation a single institute experience in taiwan |
| topic | Children Cytomegalovirus Hematopoietic stem cell transplantation Letermovir Prophylaxis |
| url | http://www.sciencedirect.com/science/article/pii/S1684118222000184 |
| work_keys_str_mv | AT chaonengcheng letermovirprophylaxisforcytomegalovirusreactivationinchildrenwhounderwenthematopoieticstemcelltransplantationasingleinstituteexperienceintaiwan AT sinsyueli letermovirprophylaxisforcytomegalovirusreactivationinchildrenwhounderwenthematopoieticstemcelltransplantationasingleinstituteexperienceintaiwan AT yunhsuanyeh letermovirprophylaxisforcytomegalovirusreactivationinchildrenwhounderwenthematopoieticstemcelltransplantationasingleinstituteexperienceintaiwan AT chingfenshen letermovirprophylaxisforcytomegalovirusreactivationinchildrenwhounderwenthematopoieticstemcelltransplantationasingleinstituteexperienceintaiwan AT jiannshiuhchen letermovirprophylaxisforcytomegalovirusreactivationinchildrenwhounderwenthematopoieticstemcelltransplantationasingleinstituteexperienceintaiwan |